MPM Capital Appoints Pablo J. Cagnoni, M.D., Former Onyx (AMGN) President, As Managing Director And CEO Of MPM Immunotherapy Portfolio Company Vesuvius.

SAN FRANCISCO--(BUSINESS WIRE)--MPM Capital announces the appointment of former President of Onyx Pharmaceuticals Pablo J. Cagnoni, M.D. as Managing Director (MD). In addition to serving as an MPM MD, Dr. Cagnoni is a co-founder of Vesuvius, an MPM-founded cancer immunotherapy company, and has taken on the role of President and Chief Executive Officer.